RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
  Impotence
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Impotence Channel

subscribe to Impotence newsletter
Latest Research : Urology : Impotence

   EMAIL   |   PRINT
Erectile dysfunction (ED) also associated with other chronic diseases and their risk factors

Jan 25, 2006 - 12:14:00 AM , Reviewed by: Priya Saxena
"Mitigation of these risk factors may ameliorate the burden of ED"

 
[RxPG] Erectile dysfunction (ED) affects approximately one in five American men, appears to be associated with cardiovascular and other chronic diseases and may predict severity and a poor prognosis among those with heart disease, according to three studies in the January 23 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

New medications for ED, introduced in 1998, prompted a 50 percent increase in physician visits related to the condition from 1996 to 2000, according to background information in one of the articles. Most previous estimates of the impact of ED have either excluded some men based on age, ethnicity or profession or were compiled before these medications became available. This led the National Institutes of Health Consensus Development Panel on Impotence to call for national epidemiological data to provide information about prevalence and risk factors for ED, the authors write.

Christopher S. Saigal, M.D., M.P.H., The David Geffen School of Medicine at UCLA, Los Angeles, and colleagues at the Urologic Diseases in America Project analyzed data from the 2001-2002 National Health and Nutrition Examinational Survey (NHANES). A total of 2,126 men age 20 years and older responded to the survey, answered questions about sexual function and underwent a physical examination. Men who said they were sometimes or never able to maintain an erection adequate for sexual intercourse were defined as having ED.

According to that definition, overall prevalence of ED was 18.4 percent, the authors report. ED occurred more often as men aged, affecting 6.5 percent of men aged 20 to 29 years and 77.5 of those aged 75 years and older. When considering other factors that might contribute to ED, including age and other medical conditions, Hispanic men had almost twice the risk of ED as white men. Obesity, hypertension, smoking and diabetes also were associated with risk of ED. "Mitigation of these risk factors may ameliorate the burden of ED," the authors write.



Publication: January 23 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals
On the web: Arch Intern Med. 2006;166:207-212 

Advertise in this space for $10 per month. Contact us today.


Related Impotence News
Smoking Increases the Risk of Erectile Dysfunction
Healthy lifestyle could fight erectile dysfunction
Erectle Dysfunction Common In Primary Care Patients
Erectile dysfunction (ED) also associated with other chronic diseases and their risk factors
Mechanism of erectile dysfunction in diabetes

Subscribe to Impotence Newsletter

Enter your email address:


 Additional information about the news article
This study was supported in part by the National Institute of Diabetes & Digestive & Kidney Diseases, Bethesda, Md. Drs. Wessells and Saigal have received grant funding from the National Institute of Diabetes & Digestive & Kidney Diseases. Dr. Wessells is a speaker for Pfizer.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)